跳至主要内容
临床试验/NCT02937649
NCT02937649招募中不适用

Multicentric Randomized Prospective Study Assessing the Impact of the Bougie Calibration Size During Laparoscopic Sleeve Gastrectomy on the Rate of Postoperative Staple-line Leak Rate

Assistance Publique - Hôpitaux de Paris12 个研究点 分布在 1 个国家目标入组 1,658 人开始时间: 2020年10月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
1,658
试验地点
12
主要终点
Postoperative gastric leak rate

研究概览

简要总结

Staple-line leak is the most frequent and incapacitating complication after laparoscopic sleeve gastrectomy (LSG). The aim of this prospective randomized trial is to compare the staple-line leak rate after LSG according to the use of a standard bougie calibre (34, 36 or 38 Fr) or 48-Fr, assuming that a higher diameter is correlated with a lower risk of leak, without lowering long-term weight loss.

详细描述

Laparoscopic sleeve gastrectomy (LSG) has become an increasing bariatric procedure. The most common complication is gastric leak from the staple line, observed in approximately 3% of cases, and can result in long and incapacitating treatment. The diameter of the bougie used to calibrate the remnant stomach could impact the rate of gastric leak, a higher diameter being correlated with a lower risk of leak, without lowering long-term weight loss.

The aim of this prospective randomized trial is to compare the outcomes of LSG according to the use of a standard care bougie calibre or 48-Fr on postoperative gastric leak and mid-term weight loss.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients between 18 and 70 years
  • •Sleeve gastrectomy as a primary bariatric procedure
  • •Body Mass Index (BMI) > 40 kg/m² or > 35 kg/m² associated with at least one comorbidity susceptible to improve after surgery (including arterial hypertension, obstructive sleep apnea syndrome and other severe respiratory disorders, severe metabolic disorders, particularly type 2 diabetes, incapacitating osteo-articular disorders, non alcoholic steatohepatitis)
  • •Decision for intervention after multidisciplinary discussion
  • •Written informed consent

排除标准

  • •Previous upper abdominal surgery (cholecystectomy excepted)
  • •ASA (American Society of Anesthesiologists) score > 3
  • •Ongoing pregnancy or breast feeding
  • •Esophagus pathology or disorder (esophageal varices, esophageal diverticula, esophageal tumors, esophageal strictures)
  • •Coagulation disorder
  • •Patient not covered by social security service and patient on AME
  • •Patient under legal guardianship and trusteeship
  • •Patient with known silicon allergy (calibration bougie contains medical silicon)
  • •More generally, all other contraindications to the use of esophageal bougie MID-TUBE that have been the subject of a scientific paper or have been identified by the practitioner or practitioners

研究组 & 干预措施

Laparoscopic sleeve gastrectomy using 48-Fr bougie

Experimental

Patients will undergo laparoscopic sleeve gastrectomy with a 48-Fr (16 mm) bougie

干预措施: Laparoscopic sleeve gastrectomy using 48-Fr bougie (Procedure)

Laparoscopic sleeve gastrectomy using standard care bougie

Active Comparator

Patients will undergo laparoscopic sleeve gastrectomy with a standard care bougie (34, 36 or 38-Fr)

干预措施: Laparoscopic sleeve gastrectomy using standard care bougie (Procedure)

结局指标

主要结局

Postoperative gastric leak rate

时间窗: 30 days following the procedure

Postoperative gastric leak rate during the first month following the procedure will be proven either on: * Morphologic examination (with contrast ingestion) * Blue dye test during surgical reintervention or postoperative course * Contrast opacification during endoscopy

次要结局

  • Postoperative morbidity rate(90 days following the procedure)
  • Short-term weight loss(At 3 and 6 months after the procedure)
  • Mid-term weight loss(At 1 and 2 years after the procedure)
  • Quality of life related to health(At 3 months, 6 months, 1 year and 2 years after the procedure)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验